All articles tagged: Mantle cell lymphoma, intra-abdominal lymph nodes (C83.13)


HealthDay 21 December at 04.47 PM American Society of Hematology, Dec. 9 to 12 The annual meeting of the American Society of Hematology was held from Dec. 9 to 12 in San Diego and attracted participants from around the world, including hematology specialists as well as clinical practitioners and other health care professionals. The conference featured presentations focusing on the diagnosis, treatment, and # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 14 December at 05.00 PM ASH: Ibrutinib-Venetoclax Beneficial for Relapsed/Refractory Lymphoma For patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), ibrutinib combined with venetoclax provides a progression-free survival benefit, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 9 to 12 in San Diego.Michael Wang, M.D., from the University of Texas MD Anderson Can # Pharmacy # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

HealthDay 21 December at 04.47 PM

American Society of Hematology, Dec. 9 to 12

The annual meeting of the American Society of Hematology was held from Dec. 9 to 12 in San Diego and attracted participants from around the world, including hematology specialists as well as clinical practitioners and other health care professionals. The conference featured presentations focusing on the diagnosis, treatment, and

# Hematology & Oncology

0 Likes

0 Comments

HealthDay 14 December at 05.00 PM

ASH: Ibrutinib-Venetoclax Beneficial for Relapsed/Refractory Lymphoma

For patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), ibrutinib combined with venetoclax provides a progression-free survival benefit, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 9 to 12 in San Diego.Michael Wang, M.D., from the University of Texas MD Anderson Can

# Pharmacy # Hematology & Oncology

0 Likes

0 Comments


Medpage Today 23 June at 09.21 PM Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D ORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 22 June at 06.00 PM Fenofibrate Slows Diabetic Retinopathy Progression ORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 22 June at 06.00 PM Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic Stroke TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 22 June at 05.20 PM Lawsuit could challenge trust in Ozempic and other popular weight loss drugs The manufacturers of the most popular weight loss drugs are being challenged in court. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 21 June at 03.38 PM Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is Low The overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 13 June at 06.56 PM Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break? Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Medpage Today 08 June at 04.00 PM Here Are the Top Supreme Court Health Cases to Watch By early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 07 June at 07.00 PM Paxlovid Fails First Test in Long COVID A 15-day course of the antiviral nirmatrelvir-ritonavir (Paxlovid) didn't improve symptoms of long COVID, according to a randomized controlled trial that was stopped early for lack of efficacy. The STOP-PASC trial showed no... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 05 June at 07.27 AM USPSTF Recommends Exercise to Prevent Falls in Older Adults Exercise is recommended to help prevent falls and fall-related morbidity in community-dwelling adults aged 65 years and older who are at increased risk for falls. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 03 June at 09.24 PM Louisiana Lawmakers Approve Surgical Castration for Sex Crimes Against Kids A person found guilty of a sex crime against a child in Louisiana could soon be ordered to undergo surgical castration, in addition to prison time. Louisiana lawmakers gave final approval to a bill Monday that would allow judges... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn